Rivaroxaban Tablet, Film Coated
Product Images NDC 50228-513

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rivaroxaban (NDC 50228-513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals,inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

180 Tablets-label (180 Tablets Label)

This text provides information on a medication containing 2.5 mg of rivaroxaban, USP. The usual dosage and storage instructions are included. It also mentions the manufacturer, ScieGen Pharmaceuticals, Inc., and provides a link to print the Medication Guide. The medication is in tablet form, with 180 tablets in the pack. The National Drug Code (NDC) for this medication is 50228-513-18. It emphasizes that the Medication Guide should be dispensed to each patient.*

FDA Label Image

Fig_10.jpg (Fig 10)

FDA Label Image

Fig_11.jpg (Fig 11)

This text appears to be a table showing the Cumulative Incidence Rate (%) over days from randomization for a study comparing a placebo group with a treatment group. The data includes the number of subjects studied for each time point.*

FDA Label Image

Fig_12.jpg (Fig 12)

FDA Label Image

Fig_2.jpg (Fig 2)

This text provides a description of the population characteristics, including information on different health conditions such as end-stage renal disease and renal impairment, along with age ranges, body weight categories, and hepatic impairment levels. Additionally, it presents fold change and 90% confidence intervals for certain conditions.*

FDA Label Image

Fig_3.jpg (Fig 3)

FDA Label Image

Fig_9.jpg (Fig 9)

This text provides data on a clinical trial comparing the effects of Rivaroxaban (a medication) versus a Placebo. The table shows the Cumulative Incidence Rate (%) and Hazard Ratio with 95% confidence intervals. It also lists the number of subjects at risk for each group over the course of the trial in days from randomization. The information suggests that Rivaroxaban may have an impact on the incidence rate compared to the placebo.*

FDA Label Image

Rivaroxaban Structure.jpg (Rivaroxaban Structure)

FDA Label Image

Label_60 Tablets (Label 60 Tablets)

Each tablet contains 2.5 mg of rivaroxaban, USP. The usual dosage and storage instructions are provided. The medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY, with 60 tablets in a pack. The Medication Guide can be printed from the given website. It is important to keep the medication out of reach of children. Each patient should be dispensed the accompanying Medication Guide. It is for prescription use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.